Blog

ACS Journal Cancer Editor-in-Chief, Suresh S. Ramalingam, is sharing the primary results of the phase 3 LAURA trial at ASCO

Photo taken from ACS Journal Cancer/X

May 24, 2024, 14:15

ACS Journal Cancer Editor-in-Chief, Suresh S. Ramalingam, is sharing the primary results of the phase 3 LAURA trial at ASCO

ACS Journal Cancer shared the following on X:

“Our Editor-in-Chief, Suresh S. Ramalingam, is sharing the primary results of the phase 3 LAURA trial at this year’s ASCO Plenary Session! ICYMI: Dr. Ramalingam and Ticiana Batista recently authored an editorial on the 20th anniversary of EGFR.”

Source: ACS Journal Cancer/X
>

ACS Journal Cancer ASCO Plenary Session cancer Cancer research cancer treatment clinical trial Editor-in-Chief editorial EGFR healthcare medical journal Medical Research OncoDaily Oncology phase 3 LAURA trial Research Suresh S. Ramalingam Ticiana Batista

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage